73 results
DEFM14A
HARP
Harpoon Therapeutics Inc
8 Feb 24
Proxy related to merger
7:00am
with the Merger. In connection with this engagement, the Board requested that Centerview evaluate the fairness, from a financial point of view … to receive an offer to acquire the company. The representatives of Goodwin also reviewed the terms of the proposed engagement of Centerview as Harpoon’s
PREM14A
HARP
Harpoon Therapeutics Inc
29 Jan 24
Preliminary proxy related to merger
4:52pm
with this engagement, the Board requested that Centerview evaluate the fairness, from a financial point of view, to the holders of Company Shares (other … an offer to acquire the company. The representatives of Goodwin also reviewed the terms of the proposed engagement of Centerview as Harpoon’s financial
DEFA14A
HARP
Harpoon Therapeutics Inc
8 Jan 24
Additional proxy soliciting materials
8:04am
Partners LLC, an accurate and complete copy of whose engagement letter has been made available to Parent, no agent, broker, investment banker, finder … or independent contractor with respect to the Company in relation to the engagement of any individual is pending or, to the knowledge of the Company
8-K
EX-2.1
HARP
Harpoon Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
, an accurate and complete copy of whose engagement letter has been made available to Parent, no agent, broker, investment banker, finder, Person or firm … contractor with respect to the Company in relation to the engagement of any individual is pending or, to the knowledge of the Company, threatened, nor
8-K
EX-99.1
y6sdttfr687la5s
23 Oct 23
Other Events
8:00am
PRE 14A
327md1r5imabkkzna
14 Apr 23
Preliminary proxy
4:54pm
8-K
EX-99.2
6pb46z4u6b iwn
12 Dec 22
Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma
4:03pm
8-K
EX-99.1
4qu22f rp5
10 Aug 22
Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
vboqikh 3hruxad
3 Jun 22
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
kp47l7
10 Mar 22
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
8d06rcg2jm647i
11 Jan 22
Other Events
6:16am